This individual will set scientific direction for the group, lead a team of approximately 8 scientists and associates, and deploy screening and HTB capabilities in direct support of drug discovery programs spanning multiple therapeutic areas including oncology, immunology, neuroscience, metabolic disease, ophthalmology, and infectious disease. Apply high throughput biology platforms including CRISPR-based approaches, DRUG-seq, high content imaging, cell painting, and complex biological models to enable target identification, hit finding, compound profiling, and lead optimization.